Pregnancy and children: quality matters most here - oxidation is an unresolved precaution in animal data, so certified-fresh products only. Fish-allergic individuals should discuss with a clinician; contaminants like mercury are effectively a solved problem in refined oils. Anyone on anticoagulants, with a heart-rhythm history, or heading into surgery should treat dosing as a clinical decision.
SOURCE LIBRARY · Imported evidence summary · Clinical review pending
Safety, with numbers attached
The harms are real, dose-dependent, and small in absolute terms - which is exactly how they should be presented.
Atrial fibrillation
Risk rises with dose: roughly +12% relative risk at ≤1 g/day, +49% above it - about a 1% absolute excess over 5 years at 4 g/day. EU regulators now list it on prescription labels. New palpitations or an irregular heartbeat: stop and see a doctor.
Bleeding
No overall excess across 120,000+ trial patients. High-dose purified EPA adds ~0.6% absolute risk - one extra bleed per 166 people. Surgical studies show no need for routine pre-op stopping, but tell your surgeon.
Cholesterol
A molecule choice, not a class effect: high-dose DHA products can raise LDL 14-19%; EPA-only lowers it slightly. If LDL matters to you, that decides the product.
Stomach and digestion
The commonest complaint - fishy burps, loose stools - and it tracks the formulation. Taking capsules with meals, splitting the dose, or switching form solves most of it.
Key evidence
- [21]Gencer B, et al. Effect of long-term marine omega-3 fatty acid supplementation on the risk of atrial fibrillation: systematic review and meta-analysis. Circulation. 2021;144:1981-1990.
- [1]Bhatt DL, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia (REDUCE-IT). N Engl J Med. 2019;380:11-22.
- [29]Griscom PV. Omega-3 Fatty Acids Are Not One Intervention: A Moderator-Matrix Review. 2026. Literature searched through July 2026. Umbrella source for this guide; claims without a numbered primary citation are synthesized there.